Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds.

Marco TagliamentoCarlo GenovaGiovanni RossiSimona CocoErika RijavecMaria Giovanna Dal BelloSimona BoccardoFrancesco GrossiAngela Alama

Published in: Expert opinion on investigational drugs (2019)

Chemotherapy maintains a pivotal role in the treatment of NSCLC. New generation agents that have the potential to overcome the mechanisms of resistance to the available drugs may provide new therapeutic opportunities. Predictive biomarkers derived from combination strategies and phase III studies are necessary going forward.

Keyphrases

phase iii
clinical trial
small cell lung cancer
squamous cell carcinoma
randomized controlled trial
radiation therapy
phase ii
advanced non small cell lung cancer
climate change
study protocol
smoking cessation